Vuong Trieu - 28 Oct 2026 Form 4 Insider Report for Oncotelic Therapeutics, Inc. (OTLC)

Reporting relationship: CHAIRMAN AND CEO, Director, 10%+ Owner
Issuer ticker: OTLC
Reported as of: 28 Oct 2026
Net transaction value: +$23,537
SEC form: 4
Accepted by SEC: 30 Oct 2026, 09:00:02 UTC
Prior SEC filing: 14 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Vuong Trieu

Filing notes and source

Key filing fact

Vuong Trieu filed Form 4 for Oncotelic Therapeutics, Inc. (OTLC) on 30 Oct 2026.

Key facts

This page summarizes Vuong Trieu's Form 4 filing for Oncotelic Therapeutics, Inc. (OTLC).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 30 Oct 2026, 09:00.

Change

Previous filing in this sequence was filed on 14 Jul 2026.
Current net transaction value: +$23,537.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001587074 Primary reporting owner

Trieu Vuong

Relationship: CHAIRMAN AND CEO, Director, 10%+ Owner
Address: 29397 AGOURA RD SUITE 107, AGOURA HILLS
Signature: /s/ Vuong Trieu
Signature date: 30 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OTLC transaction

Common Stock

Purchase

Transaction value: $17,765
Shares: +1,044,990
Change %: +1.1%
Price: $0.0170
Shares after: 95,481,309
Date: 29 Oct 2026
Ownership: Direct
Footnotes: F1

OTLC transaction

Common Stock

Purchase

Transaction value: $5,772
Shares: +312,000
Change %: +0.33%
Price: $0.0185
Shares after: 94,436,319
Date: 28 Oct 2026
Ownership: Direct
Footnotes: F2

OTLC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 16,780,384
Date: 28 Oct 2026
Ownership: By Autotelic Inc.

OTLC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 6,872,529
Date: 28 Oct 2026
Ownership: By spouse

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

On October 29, 2026, Dr. Vuong Trieu purchased 1,044,990 shares of Oncotelic Therapeutics, Inc. in his individual capacity, from the open market at a price of $0.017.

Footnote F2

On October 28, 2026, Dr. Vuong Trieu purchased 312,000 shares of Oncotelic Therapeutics, Inc. in his individual capacity, from the open market at a price of $0.0185.